SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
0.446
-0.020 (-4.37%)
At close: Feb 21, 2025, 4:00 PM
0.451
+0.005 (1.17%)
After-hours: Feb 21, 2025, 6:58 PM EST
SciSparc Employees
SciSparc had 3 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$582,333
Profits / Employee
-$1,894,667
Market Cap
1.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
SPRC News
- 5 days ago - SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology - GlobeNewsWire
- 18 days ago - SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico - GlobeNewsWire
- 5 weeks ago - SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - GlobeNewsWire
- 5 weeks ago - SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles - GlobeNewsWire
- 6 weeks ago - SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results - GlobeNewsWire
- 6 weeks ago - Why Is Psychedelic-SciSparc Stock Trading Higher On Monday? - Benzinga
- 6 weeks ago - SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment - GlobeNewsWire
- 7 weeks ago - SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder - GlobeNewsWire